Moreover, ASK1 silencing not only restored the metastatic potential of MTA2-knockdown cervical cancer cells (Fig. 4C) and MMP12 expression (Fig. 4D) but also diminished the activation of MEK3 and p38 in response to MTA2 knockdown (Fig. 4D). The gene discussed is MAP2K3; the disease is cervical carcinoma.